BFI CO., LLC sold 50.0% of their position (30K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $1.49M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/15/2018ACC: 0001144204-18-045022
-30K
Net shares
Net seller
$1.49M
Total sold
3
Open market trades
0B · 3S
5
Total transactions
60K acquired · 90K disposed
Non-Derivative Transactions4
Class A Common Stock
Direct
Shares
+60K
Price / share
—
Trade value
—
% of position
New position
8/13/2018
0.00→60K
Class A Common Stock
Direct
Shares
−10K
Price / share
$50.03
Trade value
$500.30K
% of position
16.7%
8/13/2018
60K→50K
Class A Common Stock
Direct
Shares
−10K
Price / share
$49.90
Trade value
$499K
% of position
20.0%
8/14/2018
50K→40K
Class A Common Stock
Direct
Shares
−10K
Price / share
$49.33
Trade value
$493.30K
% of position
25.0%
8/15/2018
40K→30K
Total
Net shares
+30K
Net value
-$1.49M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 8/13/2018 | C · Conversion | +60K | — | — | New position | 0.00 | 60K |
| Class A Common Stock Direct | 8/13/2018 | S · Sale | −10K | $50.03 | $500.30K | 16.7% | 60K | 50K |
| Class A Common Stock Direct | 8/14/2018 | S · Sale | −10K | $49.90 | $499K | 20.0% | 50K | 40K |
| Class A Common Stock Direct | 8/15/2018 | S · Sale | −10K | $49.33 | $493.30K | 25.0% | 40K | 30K |
| Total | +30K | -$1.49M | ||||||
Derivative Transactions1
Class B Common Stock
Direct
Converts to
Class A Common Stock
60K shares
Shares
−60K
Strike price
0
Held after
20.25M
Exercisable
—
8/13/2018
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Class B Common Stock Direct | Class A Common Stock60K shares | 8/13/2018 | C · Conversion | −60K | 0 | — | 20.25M |